If ALT increases during follow-up (ALT ≥ 500 U/L together with documented increased viral load) or clinical hepatitis exacerbation, it is recommended to add immunosuppressive therapy, with corticosteroids to be tapered very slowly, with a close monitoring of LFT’s, to prevent evolution to fulminant hepatic failure. The gene discussed is GPT; the disease is hepatitis A virus infection.